Characterization of Microbiota in Children with Chronic Functional Constipation

Tim G J de Meij, Evelien F J de Groot, Anat Eck, Andries E Budding, C M Frank Kneepkens, Marc A Benninga, Adriaan A van Bodegraven, Paul H M Savelkoul, Tim G J de Meij, Evelien F J de Groot, Anat Eck, Andries E Budding, C M Frank Kneepkens, Marc A Benninga, Adriaan A van Bodegraven, Paul H M Savelkoul

Abstract

Objectives: Disruption of the intestinal microbiota is considered an etiological factor in pediatric functional constipation. Scientifically based selection of potential beneficial probiotic strains in functional constipation therapy is not feasible due to insufficient knowledge of microbiota composition in affected subjects. The aim of this study was to describe microbial composition and diversity in children with functional constipation, compared to healthy controls.

Study design: Fecal samples from 76 children diagnosed with functional constipation according to the Rome III criteria (median age 8.0 years; range 4.2-17.8) were analyzed by IS-pro, a PCR-based microbiota profiling method. Outcome was compared with intestinal microbiota profiles of 61 healthy children (median 8.6 years; range 4.1-17.9). Microbiota dissimilarity was depicted by principal coordinate analysis (PCoA), diversity was calculated by Shannon diversity index. To determine the most discriminative species, cross validated logistic ridge regression was performed.

Results: Applying total microbiota profiles (all phyla together) or per phylum analysis, no disease-specific separation was observed by PCoA and by calculation of diversity indices. By ridge regression, however, functional constipation and controls could be discriminated with 82% accuracy. Most discriminative species were Bacteroides fragilis, Bacteroides ovatus, Bifidobacterium longum, Parabacteroides species (increased in functional constipation) and Alistipes finegoldii (decreased in functional constipation).

Conclusions: None of the commonly used unsupervised statistical methods allowed for microbiota-based discrimination of children with functional constipation and controls. By ridge regression, however, both groups could be discriminated with 82% accuracy. Optimization of microbiota-based interventions in constipated children warrants further characterization of microbial signatures linked to clinical subgroups of functional constipation.

Conflict of interest statement

P.H.M Savelkoul and A.E. Budding have proprietary rights on the IS-pro platform technology (patent ‘Microbial population analysis’, WO2008/125365) and are co-founders of a spin-off company developing this technique into a clinical diagnostic product. This patent is only related to the microbiota profiling technique IS-pro. This does not alter our adherence to all PLOS ONE policies on sharing data and materials.

Figures

Fig 1. Clustered heat map with IS…
Fig 1. Clustered heat map with IS profiles of children with functional constipation and controls.
Clustered heat map displaying IS profiles of 76 children with functional constipation and 61 healthy controls. Individual subjects are shown on the X axis; children with constipation in red, healthy controls in green. On the Y axis, IS fragment lengths are expressed (in number of nucleotides), corresponding with bacterial strain type (OTU). Blue peaks represent Firmicutes, Actinobacteria, Fusobacteria, Verrucomicrobia (FAFV), red peaks represent Bacteroidetes and yellow peaks represent Proteobacteria. Intensity of colors reflect relative dominance of each indicated bacterial strain, grey signals represent less prevalent IS fragment lengths. No disease-specific clustering was observed, indicating that the groups could not be distinguished based on IS profiles using this unsupervised method. The most abundant OTUs in both study groups were observed within the phylum Bacteriodetes, corresponding to the species Bacteroides vulgatis (480 nt), Alistipes putredinis (220 nt) and Alistipes finegoldii (401 nt).
Fig 2. Principle coordinate analysis of microbial…
Fig 2. Principle coordinate analysis of microbial profiles of children with and without functional constipation.
Principle coordinate analysis scatterplot displaying overall bacterial community composition, showing no separate clustering of microbial profiles of children with functional constipation (red dots) and controls (green dots) for all phyla together (A) and per phylum (B: Bacteroidetes; C: Firmicutes, Actinobacteria, Fusobacteria, Verrucomicrobia (FAFV); D: Proteobacteria).
Fig 3. Diversity indices of children with…
Fig 3. Diversity indices of children with functional constipation and healthy controls.
Shannon diversity index of children with functional constipation (dark colors) and healthy controls (light colors), showing similar indices, both when taken all phyla together, as well as on phylum level. Green: all phyla taken together. Red: Bacteroidetes, blue: represent Firmicutes, Actinobacteria, Fusobacteria, Verrucomicrobia (FAFV), yellow: Proteobacteria.
Fig 4. Receiver operating characteristic (ROC) curves…
Fig 4. Receiver operating characteristic (ROC) curves for the discrimination of children with and without functional constipation.
Receiver operating characteristic (ROC) curves summarizing the predictive power of the cross-validated logistic ridge regression model for clinical status per phylum and for all phyla combined.

References

    1. Mugie SM, Di Lorenzo C, Benninga MA. Constipation in childhood. Nat Rev Gastroenterol Hepatol. 2011. August 2;8(9):502–11. 10.1038/nrgastro.2011.130
    1. Tabbers MM, DiLorenzo C, Berger MY, Faure C, Langendam MW, Nurko S et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr 2014;58:265–81.
    1. Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams JS, Staiano A, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology 2006;130:1527–37. 10.1053/j.gastro.2005.08.063
    1. Benninga MA, Voskuijl WP, Taminiau JA. Childhood constipation: is there new light in the tunnel? J Pediatr Gastroenterol Nutr 2004;39:448–464.
    1. Rajindrajith S, Devanarayana NM, Weerasooriya L, Hathagoda W, Benninga MA. Quality of life and somatic symptoms in children with constipation: a school-based study. J Pediatr 2013;163:1069–72. 10.1016/j.jpeds.2013.05.012
    1. Zoppi G, Cinquetti M, Luciano A, Benini A, Muner A, Bertazzoni Minelli E. The intestinal ecosystem in chronic functional constipation. Acta Paediatr 1998;87:836–41.
    1. Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R et al. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 2005;100:2560–8. 10.1111/j.1572-0241.2005.00230.x
    1. Khalif IL, Quigley EM, Konovitch EA, Maximova ID. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis 2005;37:838–49. 10.1016/j.dld.2005.06.008
    1. Furnari M, Savarino E, Bruzzone L, Moscatelli A, Gemignani L, Giannini EG, et al. Reassessment of the role of methane production between irritable bowel syndrome and functional constipation. J Gastrointestin Liver Dis 2012;21:157–63.
    1. Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009;6:306–14. 10.1038/nrgastro.2009.35
    1. Tabbers MM, de Milliano I, Roseboom MG, Benninga MA. Is Bifidobacterium breve effective in the treatment of childhood constipation? Results from a pilot study. Nutr J. 2011. February 23;10:19 10.1186/1475-2891-10-19
    1. Coccorullo P, Strisciuglio C, Martinelli M, Miele E, Greco L, Staiano A. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. J Pediatr. 2010. October;157(4):598–602. 10.1016/j.jpeds.2010.04.066
    1. Sadeghzadeh M, Rabieefar A, Khoshnevisasl P, Mousavinasab N, Eftekhari K. The effect of probiotics on childhood constipation: a randomized controlled double blind clinical trial. Int J Pediatr. 2014;2014:937212 10.1155/2014/937212
    1. Quigley EM. The enteric microbiota in the pathogenesis and management of constipation. Best Pract Res Clin Gastroenterol 2011;25:119–26. 10.1016/j.bpg.2011.01.003
    1. Budding AE, Grasman ME, Lin F, Bogaards JA, Soeltan-Kaersenhout DJ, Vandenbroucke-Grauls CM, van Bodegraven AA, et al. IS-pro: high-throughput molecular fingerprinting of the intestinal microbiota. FASEB J 2010;24:4556–64. 10.1096/fj.10-156190
    1. de Meij TG, Budding AE, de Groot EF, Jansen FM, Frank Kneepkens CM, Benninga MA, et al. Composition and stability of intestinal microbiota of healthy children within a Dutch population. FASEB J. 2015. pii: fj.15-278622.
    1. Kashyap PC, Marcobal A, Ursell LK, Larauche M, Duboc H, Earle KA, et al. Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice. Gastroenterology 2013;144:967–77. 10.1053/j.gastro.2013.01.047
    1. Verdu EF. Probiotics effects on gastrointestinal function: beyond the gut? Neurogastroenterol Motil 2009;21:477–80. 10.1111/j.1365-2982.2009.01297.x
    1. Caenepeel P, Janssens J, Vantrappen G, Eyssen H, Coremans G. Interdigestive myoelectric complex in germ-free rats. Dig Dis Sci 1989;34:1180–4.
    1. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001;291:881–4. 10.1126/science.291.5505.881
    1. Bär F, Von Koschitzky H, Roblick U, Bruch HP, Schulze L, Sonnenborn U, et al. Cell-free supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study. Neurogastroenterol Motil 2009;21:559–66. 10.1111/j.1365-2982.2008.01258.x
    1. Husebye E, Hellström PM, Sundler F, Chen J, Midtvedt T. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 2001;280:G368–80.
    1. Ma X, Mao YK, Wang B, Huizinga JD, Bienenstock J, Kunze W. Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli. Am J Physiol Gastrointest Liver Physiol 2009; 296:G868–75. 10.1152/ajpgi.90511.2008
    1. Wang B, Mao YK, Diorio C, Wang L, Huizinga JD, Bienenstock J, et al. Lactobacillus reuteri ingestion and IK(Ca) channel blockade have similar effects on rat colon motility and myenteric neurones. Neurogastroenterol Motil 2010;22:98–107. 10.1111/j.1365-2982.2009.01384.x
    1. Guarino MP, Altomare A, Stasi E, Marignani M, Severi C, Alloni R, et al. Effect of acute mucosal exposure to Lactobacillus rhamnosus GG on human colonic smooth muscle cells. J Clin Gastroenterol 2008;42(Suppl 3):S185–90.
    1. Soares AC, Lederman HM, Fagundes-Neto U, de Morais MB. Breath methane associated with slow colonic transit time in children with chronic constipation. J Clin Gastroenterol 2005;39:512–5.
    1. Attaluri A, Jackson M, Valestin J, Rao S. Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am J Gastroenterol 2010;105:1407–11. 10.1038/ajg.2009.655
    1. Parthasarathy G, Chen J, Chen X, Chia N, O'Connor HM, Wolf PG, et al. Relationship between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation. Gastroenterology. 2016. February;150(2):367–79. 10.1053/j.gastro.2015.10.005
    1. Zhu L, Liu W, Alkhouri R, Baker RD, Bard JE, Quigley EM, et al. Structural changes in the gut microbiome of constipated patients. Physiol Genomics 2014;46:679–86. 10.1152/physiolgenomics.00082.2014
    1. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006. December 21;444(7122):1022–3. 10.1038/4441022a
    1. Daniels L, Budding AE, de Korte N, Eck A, Bogaards JA, Stockmann HB, et al. Fecal microbiome analysis as a diagnostic test for diverticulitis. Eur J Clin Microbiol Infect Dis 2014;33:1927–36. 10.1007/s10096-014-2162-3
    1. Lozupone CA, Stombaugh J, Gonzalez A, Ackermann G, Wendel D, Vázquez-Baeza Y, et al. Meta-analyses of studies of the human microbiota. Genome Res. 2013. October;23(10):1704–14. 10.1101/gr.151803.112
    1. Knights D, Costello EK, Knight R. Supervised classification of human microbiota. FEMS Microbiol Rev. 2011. March;35(2):343–59. 10.1111/j.1574-6976.2010.00251.x
    1. Wang F, Kaplan JL, Gold BD, Bhasin MK, Ward NL, Kellermayer R, et al. Detecting Microbial Dysbiosis Associated with Pediatric Crohn Disease Despite the High Variability of the Gut Microbiota. Cell Rep. 2016. February 2;14(4):945–55. 10.1016/j.celrep.2015.12.088
    1. Fredricks DN, Relman DA. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev. 1996. January;9(1):18–33.
    1. Budding AE, Grasman ME, Eck A, Bogaards JA, Vandenbroucke-Grauls CM, van Bodegraven AA, et al. Rectal swabs for analysis of the intestinal microbiota. PLoS One. 2014. July 14;9(7):e101344 10.1371/journal.pone.0101344

Source: PubMed

3
Předplatit